Patents by Inventor Wade M. Demmer

Wade M. Demmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200121931
    Abstract: An implantable medical device includes an activity sensor, a pulse generator, and a control module. The control module is configured to determine activity metrics from the activity signal and determine an activity metric value at a predetermined percentile of the activity metrics. The control module sets a lower pacing rate set point based on the activity metric value at the predetermined percentile.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 23, 2020
    Inventors: Todd J. SHELDON, Wade M. DEMMER, Karen J. KLECKNER, Douglas A. PETERSON, Paul R. SOLHEIM
  • Publication number: 20200121932
    Abstract: An intracardiac ventricular pacemaker is configured to detect a ventricular diastolic event from a motion signal received by a pacemaker control circuit from a motion sensor. The control circuit starts an atrial refractory period having an expiration time set based on a time of the detection of the ventricular diastolic event. The control circuit detects an atrial systolic event from the motion signal after expiration of the atrial refractory period and controls a pulse generator of the pacemaker to deliver a pacing pulse to a ventricle of a patient's heart at a first atrioventricular pacing time interval after the atrial systolic event detection.
    Type: Application
    Filed: December 19, 2019
    Publication date: April 23, 2020
    Inventors: Vincent E. SPLETT, Todd J. SHELDON, Yong K. CHO, Wade M. DEMMER, Mark K. ERICKSON
  • Patent number: 10617875
    Abstract: Techniques for facilitating telemetry between a medical device and an external device are provided. In one example, a medical device includes a classification component and a communication component. The classification component is configured to determine a classification for data generated by the medical device. The classification component is also configured to determine an urgency level for an advertising data packet based on the classification for the data. The communication component is also configured to broadcast the advertising data packet for the medical device at a defined beaconing rate based on the urgency level for the advertising data packet.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: April 14, 2020
    Assignee: Medtronic, Inc.
    Inventors: Wade M. Demmer, Charles R. Gordon, Matthew R. Yoder, Val D. Eisele, Matthew P. Hanly, James R. Peichel, Nicholas C. Wine, Ryan D. Wyszynski, Eric R. Williams
  • Publication number: 20200046983
    Abstract: An intracardiac ventricular pacemaker having a motion sensor is configured to produce a motion signal including an atrial systolic event and a ventricular diastolic event indicating a passive ventricular filling phase, set a detection threshold to a first amplitude during an expected time interval of the ventricular diastolic event and to a second amplitude lower than the first amplitude after an expected time interval of the ventricular diastolic event. The pacemaker is configured to detect the atrial systolic event in response to the motion signal crossing the detection threshold and set an atrioventricular pacing interval in response to detecting the atrial systolic event.
    Type: Application
    Filed: October 16, 2019
    Publication date: February 13, 2020
    Inventors: Vincent E. SPLETT, Todd J. SHELDON, Yong K. CHO, Wade M. DEMMER, Mark K. ERICKSON
  • Publication number: 20200038665
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Application
    Filed: October 14, 2019
    Publication date: February 6, 2020
    Inventors: Hyun J. YOON, Wade M. DEMMER, Matthew J. HOFFMAN, Robert A. BETZOLD, Jonathan D. EDMONSON, Michael L. ELLINGSON, Mark K. ERICKSON, Ben W. HERBERG, Juliana E. PRONOVICI, James D. REINKE, Todd J. SHELDON, Paul R. SOLHEIM
  • Publication number: 20200038664
    Abstract: The control module of a first pacemaker included in an implantable medical device system including the first pacemaker and a second pacemaker is configured to set a pacing escape interval in response to a far field pacing pulse sensed by the first pacemaker. The far field pacing pulse is a pacing pulse delivered by the second pacemaker. The pacing escape interval is allowed to continue without restarting the in response to a far field intrinsic event sensed by the first pacemaker during the pacing escape interval. The first pacemaker delivers a cardiac pacing pulse to the heart upon expiration of the pacing escape interval.
    Type: Application
    Filed: October 14, 2019
    Publication date: February 6, 2020
    Inventors: Wade M. DEMMER, Todd J. SHELDON, Saul E. GREENHUT, James D. REINKE
  • Patent number: 10532212
    Abstract: An intracardiac ventricular pacemaker is configured to detect a ventricular diastolic event from a motion signal received by a pacemaker control circuit from a motion sensor. The control circuit starts an atrial refractory period having an expiration time set based on a time of the detection of the ventricular diastolic event. The control circuit detects an atrial systolic event from the motion signal after expiration of the atrial refractory period and controls a pulse generator of the pacemaker to deliver a pacing pulse to a ventricle of a patient's heart at a first atrioventricular pacing time interval after the atrial systolic event detection.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: January 14, 2020
    Assignee: Medtronic, Inc.
    Inventors: Vincent E Splett, Todd J Sheldon, Yong K Cho, Wade M Demmer, Mark K Erickson
  • Patent number: 10525270
    Abstract: According to some methods, for example, preprogrammed in a microprocessor element of an implantable cardiac pacing system, at least one of a number of periodic pacing threshold searches includes steps to reduce an evoked response amplitude threshold for evoked response signal detection. The reduction may be to a minimum value measurable above zero, for example, as determined by establishing a ‘noise floor’. Alternately, amplitudes of test pacing pulses and corresponding post pulse signals are collected and reviewed to search for a break, to determine a lower value to which the evoked response threshold may be adjusted without detecting noise. Subsequent to reducing the threshold, if no evoked response signal is detected for a test pulse applied at or above a predetermined maximum desirable pulse energy, an operational pacing pulse energy is set to greater than or equal to the maximum desirable in conjunction with a reduction in pacing rate.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: January 7, 2020
    Assignee: Medtronic, Inc.
    Inventors: Todd J Sheldon, Wade M Demmer
  • Patent number: 10518094
    Abstract: An implantable medical device includes an activity sensor, a pulse generator, and a control module. The control module is configured to determine activity metrics from the activity signal and determine an activity metric value at a predetermined percentile of the activity metrics. The control module sets a lower pacing rate set point based on the activity metric value at the predetermined percentile.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: December 31, 2019
    Assignee: Medtronic, Inc.
    Inventors: Todd J. Sheldon, Wade M. Demmer, Karen J. Kleckner, Douglas A. Peterson, Paul R. Solheim
  • Patent number: 10512424
    Abstract: A medical device and associated method evaluate vectors of a multi-dimensional accelerometer by receiving a signal from the accelerometer for each of the vectors and determining a metric from the signal for each of the vectors during a first sensing condition and during a second sensing condition. The difference between the metrics determined for the first sensing condition and the second sensing condition for each of the vectors is determined. One of the vectors is selected, based upon the determined differences, for monitoring the patient.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: December 24, 2019
    Assignee: Medtronic, Inc.
    Inventors: Wade M Demmer, Todd J Sheldon
  • Publication number: 20190336780
    Abstract: An implantable medical device system includes a pacemaker and an implantable cardioverter defibrillator (ICD). The pacemaker is configured to confirm a hemodynamically unstable rhythm based on an activity metric determined from an activity sensor signal after detecting a ventricular tachyarrhythmia and withhold anti-tachycardia pacing (ATP) pulses in response to confirming the hemodynamically unstable rhythm. The pacemaker may deliver ATP when a hemodynamically unstable rhythm is not confirmed based on the activity metric. The ICD is configured to detect the ATP and withhold a shock therapy in response to detecting the ATP in some examples.
    Type: Application
    Filed: July 15, 2019
    Publication date: November 7, 2019
    Inventors: Todd J. SHELDON, Wade M. DEMMER, Teresa A. WHITMAN
  • Publication number: 20190321634
    Abstract: A ventricular pacemaker is configured to determine a ventricular rate interval by determining at least one ventricular event interval between two consecutive ventricular events and determine a rate smoothing ventricular pacing interval based on the ventricular rate interval. The pacemaker is further configured to detect an atrial event from a sensor signal and deliver a ventricular pacing pulse in response to detecting the atrial event from the sensor signal. The pacemaker may start the rate smoothing ventricular pacing interval to schedule a next pacing pulse to be delivered upon expiration of the rate smoothing ventricular pacing interval.
    Type: Application
    Filed: April 18, 2019
    Publication date: October 24, 2019
    Inventors: Todd J. SHELDON, Wade M. DEMMER, Vincent P. GANION, Juliana E. PRONOVICI, Vincent E. SPLETT, Menglong XING
  • Patent number: 10449366
    Abstract: An intracardiac ventricular pacemaker having a motion sensor is configured to produce a motion signal including an atrial systolic event and a ventricular diastolic event indicating a passive ventricular filling phase, set a detection threshold to a first amplitude during an expected time interval of the ventricular diastolic event and to a second amplitude lower than the first amplitude after an expected time interval of the ventricular diastolic event. The pacemaker is configured to detect the atrial systolic event in response to the motion signal crossing the detection threshold and set an atrioventricular pacing interval in response to detecting the atrial systolic event.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: October 22, 2019
    Assignee: Medtronic, Inc.
    Inventors: Vincent E Splett, Todd J Sheldon, Yong K Cho, Wade M Demmer, Mark K Erickson
  • Patent number: 10449354
    Abstract: An elongated implantable medical device for delivering electrical stimulation pulses to a patient includes a housing having a housing proximal end and a housing distal end and an electrical conductor having a conductor proximal end and a conductor distal end. The conductor distal end extends from the housing proximal end. The housing has a first fixation force at a first implant site after being implanted in a patient's body, and the conductor proximal end has a second fixation force at a second implant site after being implanted in a patient's body. The second fixation force is different than the first fixation force.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: October 22, 2019
    Assignee: Medtronics, Inc.
    Inventors: Wade M Demmer, Matthew D Bonner, Vladimir Grubac
  • Patent number: 10441798
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: October 15, 2019
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Mark K. Erickson, Ben E. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
  • Patent number: 10441796
    Abstract: The control module of a first pacemaker included in an implantable medical device system including the first pacemaker and a second pacemaker is configured to set a pacing escape interval in response to a far field pacing pulse sensed by the first pacemaker. The far field pacing pulse is a pacing pulse delivered by the second pacemaker. The pacing escape interval is allowed to continue without restarting the in response to a far field intrinsic event sensed by the first pacemaker during the pacing escape interval. The first pacemaker delivers a cardiac pacing pulse to the heart upon expiration of the pacing escape interval.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: October 15, 2019
    Assignee: Medtronic, Inc.
    Inventors: Wade M Demmer, Todd J Sheldon, Saul E Greenhut, James D Reinke
  • Publication number: 20190308021
    Abstract: An intracardiac pacemaker system is configured to produce physiological atrial event signals by a sensing circuit of a ventricular intracardiac pacemaker and select a first atrial event input as the physiological atrial event signals. The ventricular intracardiac pacemaker detects atrial events from the selected first atrial event input, determines if input switching criteria are met, and switches from the first atrial event input to a second atrial event input in response to the input switching criteria being met. The second atrial event input includes broadcast atrial event signals produced by a second implantable medical device and received by the ventricular intracardiac pacemaker.
    Type: Application
    Filed: June 24, 2019
    Publication date: October 10, 2019
    Inventors: Wade M. DEMMER, Yong K. CHO, Mark K. ERICKSON, Todd J. SHELDON
  • Publication number: 20190308022
    Abstract: An intracardiac ventricular pacemaker having a motion sensor, a pulse generator and a control circuit coupled to the pulse generator and the motion sensor is configured to identify a ventricular systolic event, detect a ventricular passive filling event signal from the motion signal, and determine a time interval from the ventricular systolic event to the ventricular passive filling event. The pacemaker establishes a minimum pacing interval based on the time interval.
    Type: Application
    Filed: April 9, 2018
    Publication date: October 10, 2019
    Inventors: Wade M. DEMMER, Juliana E. PRONOVICI, Todd J. SHELDON
  • Publication number: 20190262604
    Abstract: Implantable medical devices automatically switch from a normal mode of operation to an exposure mode of operation and back to the normal mode of operation. The implantable medical devices may utilize hysteresis timers in order to determine if entry and/or exit criteria for the exposure mode are met. The implantable medical devices may utilize additional considerations for entry to the exposure mode such as a confirmation counter or a moving buffer of sensor values. The implantable medical devices may utilize additional considerations for exiting the exposure mode of operation and returning to the normal mode, such as total time in the exposure mode, patient position, and high voltage source charge time in the case of devices with defibrillation capabilities.
    Type: Application
    Filed: May 13, 2019
    Publication date: August 29, 2019
    Inventors: Hyun J. YOON, Michael L. ELLINGSON, Wade M. DEMMER, Jonathan D. EDMONSON, Matthew J. HOFFMAN, Ben W. HERBERG, James D. REINKE, Todd J. SHELDON, Paul R. SOLHEIM, Alison M. SEACORD
  • Publication number: 20190262620
    Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
    Type: Application
    Filed: May 13, 2019
    Publication date: August 29, 2019
    Inventors: Hyun J. YOON, Wade M. DEMMER, Matthew J. HOFFMAN, Robert A. BETZOLD, Jonathan D. EDMONSON, Michael L. ELLINGSON, Ben W. HERBERG, Juliana E. PRONOVICI, James D. REINKE, Todd J. SHELDON, Paul R. SOLHEIM